Effectiveness of vedolizumab on intestinal and articular symptoms after 10 and 22 weeks of treatment in patients with inflammatory bowel diseases: a real world study
Latest Information Update: 06 Dec 2018
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Therapeutic Use
- 06 Dec 2018 New trial record